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Abstract
Background: In rats, esophagogastroduodenal anastomosis (EGDA) without concomitant chemical carcinogen
treatment leads to gastroesophageal reflux disease, multilayered epithelium (MLE, a presumed precursor in intestinal
metaplasia), columnar-lined esophagus, dysplasia, and esophageal adenocarcinoma. Previously we have shown that
columnar-lined esophagus in EGDA rats resembled human Barrett's esophagus (BE) in its morphology, mucin features
and expression of differentiation markers (Lab. Invest. 2004;84:753–765). The purpose of this study was to compare the
phenotype of rat MLE with human MLE, in order to gain insight into the nature of MLE and its potential role in the
development of BE.
Methods: Serial sectioning was performed on tissue samples from 32 EGDA rats and 13 patients with established BE.
Tissue sections were immunohistochemically stained for a variety of transcription factors and differentiation markers of
esophageal squamous epithelium and intestinal columnar epithelium.
Results: We detected MLE in 56.3% (18/32) of EGDA rats, and in all human samples. As expected, both rat and human
squamous epithelium, but not intestinal metaplasia, expressed squamous transcription factors and differentiation markers
(p63, Sox2, CK14 and CK4) in all cases. Both rat and human intestinal metaplasia, but not squamous epithelium,
expressed intestinal transcription factors and differentiation markers (Cdx2, GATA4, HNF1α, villin and Muc2) in all
cases. Rat MLE shared expression patterns of Sox2, CK4, Cdx2, GATA4, villin and Muc2 with human MLE. However,
p63 and CK14 were expressed in a higher proportion of rat MLE compared to humans.
Conclusion: These data indicate that rat MLE shares similar properties to human MLE in its expression pattern of these
markers, not withstanding small differences, and support the concept that MLE may be a transitional stage in the
metaplastic conversion of squamous to columnar epithelium in BE.
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Barrett's esophagus (BE) is characterized by replacement
of esophageal squamous epithelium by intestinalized
columnar epithelium, most commonly due to chronic
gastroesophageal reflux disease. Patients with BE are at
increased risk for the development of esophageal adeno-
carcinoma, which is now the most rapidly increasing type
of cancer in Western countries [1].
The pathogenesis of intestinal metaplasia (IM) in BE is
poorly understood. For instance, theories regarding the
origin of stem cells that give rise to intestinalized colum-
nar epithelium include origin from esophageal squamous
epithelium or the submucosal glands [2-5]. However,
regardless of the site of origin, it is generally believed that
pluripotent stem cells are triggered by inflammatory
mediators and/or gastroesophageal refluxate to differenti-
ate into intestinalized columnar epithelium [5,6]. Recent
studies have focused on the potential roles of acid and
bile, inflammatory mediators, and intestinal transcription
factors in the pathogenesis of human BE [6-11]. Despite
these efforts, the mechanism underlying the development
of IM in BE remains unclear.
Multilayered epithelium (MLE), first described in 1997, is
a hybrid epithelium that expresses cytokeratins of both
squamous and columnar differentiation [12]. It is com-
posed of multiple layers of cells that appear squamous in
the basal portion and columnar in the superficial aspects.
Several studies have shown that MLE is predominantly
located at, or near, the neo-squamocolumnar junction in
patients with BE. Multilayered epithelium has also been
shown to correlate with BE and reflux esophagitis. Thus, it
has been postulated that MLE may represent a transitional
stage in the squamous to columnar transition in BE [13-
16].
In our laboratory, we utilized a rat surgical model to study
BE. In this model, an esophagoduodenal anastomosis was
created to induce gastroesophageal reflux. Sprague-Daw-
ley rats subjected to this procedure developed esophageal
adenocarcinoma [17]. Subsequently, we modified this
procedure by performing an esophagogastroduodenal
anastomosis (EGDA) in order to induce reflux of gastric
and duodenal contents into the esophagus. Previous stud-
ies have shown that more than 50% of rats developed
columnar-lined esophagus and adenocarcinoma 40 weeks
after surgery [18]. In rats, MLE frequently also occurs at
the neo-squamocolumnar junction, but occasionally in
the mid-esophagus as well. Rat columnar-lined esophagus
resembles human BE in its morphology, mucin features
and in its expression of intestinal differentiation markers,
such as keratin 7, keratin 20, Das-1, villin, and trefoil fac-
tor 1 [19].
The purpose of this study was to evaluate and compare
MLE in our rat model to that in humans with established
BE, in order to gain further insight into the role of MLE in
the development of BE. To perform this study, serial par-
affin-embedded esophageal tissue sections from 32 EGDA
rats were evaluated for expression patterns of transcrip-
tion factors and differentiation markers of esophageal
squamous epithelium and intestinal columnar epithe-
lium not previously evaluated. Mucosal biopsy samples
containing MLE from 13 human patients with established
BE were also studied for comparison with the rat samples.
Methods
Tissue samples
Esophagogastroduodenal anastomosis was performed on
32 rats as described previously. [18] In brief, a surgical
anastomosis was created between the gastroesophageal
junction and the duodenum, on the antimesenteric bor-
der, with accurate mucosal to mucosal opposition, in 8-
week-old male Sprague-Dawley rats. The animals were
treated with iron dextran (4 mg Fe/kg/week, i.p.) for 40
weeks. After the animals were sacrificed by CO2 asphyxi-
ation, the esophagus was removed, fixed in 10% buffered
formalin, Swiss-rolled, processed, and embedded in par-
affin. Serial sections of tissue blocks from all 32 rats (300
to 500 sections per block) were then made for this study.
For comparison, coded (with all identifiers removed)
archival formalin-fixed paraffin-embedded esophageal
mucosal biopsies from 13 patients with MLE in BE were
obtained from the files of the Department of Pathology,
Brigham and Women's Hospital, Boston, MA. The study
protocol was approved by the Institutional Review Board.
Ten serial sections of each case were used in this study. Tis-
sue sections from these 13 patients were specifically
selected because they all contained MLE, as described pre-
viously [16].
Pathological evaluation
In rat tissues, one out of every twenty serial tissue sections
was stained with hematoxylin and eosin, and then coun-
terstained with Alcian blue at pH2.5. Tissue sections were
evaluated for the presence of BE and MLE [19]. In brief, BE
was characterized by the occurrence of IM, which was
defined by the presence of goblet cells in the esophagus.
Multilayered epithelium consists of 4 to 8 layers of cells
that show squamous differentiation in the basal portion
and columnar differentiation in the superficial layers.
Serial sections that contained MLE were identified and
selected for immunohistochemical staining.
Tissue sections of human samples were simultaneously
stained with H&E and the presence of BE and MLE was
confirmed. The presence or absence of squamous epithe-
lium was also noted.Page 2 of 9
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The following four groups of markers were studied (Table
1): (1) squamous transcription factors (p63, Sox2); (2)
squamous differentiation markers (CK14, CK4); (3) intes-
tinal transcription factors (Cdx2, GATA4, HNF1α); and
(4) intestinal differentiation markers (villin, Muc2).
Briefly, paraffin-embedded tissue sections were deparaffi-
nized, rehydrated, and pretreated by heating the slides for
5–10 min in 10 mM citrate buffer. Immunohistochemical
staining was performed with the ABC kit (Vector Labs,
Capenteria, CA) according to the manufacturer's instruc-
tions. The sources of the primary antibodies, catalogue
numbers, and working concentrations are listed in Table
1. Normal serum or phosphate buffered saline were used
instead of the primary antibodies, as negative controls.
Both positive and negative control slides were processed
in parallel. Alcian blue staining (1% in 3% acetic acid,
pH2.5, for 10 min) was performed after immunohisto-
chemical staining on the same slides to visualize cells that
produce acidic mucin.
Immunohistochemical staining for each marker was
scored by one pathologist (R.Q.) as either positive or neg-
ative in the epithelium of interest. Areas of squamous epi-
thelium, MLE and IM were scored separately. For analysis
of p63, Sox2, Cdx2, GATA4, and HNF1α, epithelium with
strong nuclear staining was counted as positive. Cytoplas-
mic staining of Cdx2 was also noted. Cytoplasmic stain-
ing was counted as positive for analysis of CK4, CK14,
villin and Muc2. The frequency of positive staining for
each marker in each epithelial type was then calculated
(Table 2).
Statistical analysis
Statistical analysis was conducted with Fisher exact test for
frequency data. For each immunohistochemical stain, the
frequency of positive staining between rat and human
MLE was compared.
Results
Histopathology of rat and human samples
Twenty nine EGDA rats (29/32, 90.6%) contained BE,
defined by the presence of IM in the esophagus. Multilay-
ered epithelium was detected in 18 of 32 (56.3%) EGDA
rats. The mean number of MLE foci per rat was 2.4 (range
1 to 6). Most MLE foci (91%) were located at the neo-
squamocolumnar junction, whereas fewer were located
distant from the junction, or in the mid-esophagus. The
morphologic features of MLE in the rat model closely
resembled that of human patients [14,16,19].
Human samples containing MLE were intentionally
selected for this study. In addition, eleven samples also
had squamous epithelium within their BE biopsies.
Expression of squamous transcription factors and 
differentiation markers in rat and human samples (Figure 
1; Table 2)
Both rat and human squamous epithelium uniformly
expressed squamous transcription factors (p63 and Sox2)
and differentiation markers (CK14 and CK4) in all cases
(Figure 1A, D, G, J, M, P, S, V). P63 and Sox2 were both
expressed in the nuclei of squamous epithelial cells in the
basal cell layer. CK14 was expressed in the cytoplasm of
basal cells, and CK4 in suprabasal cells.
Neither rat nor human IM expressed any of these tran-
scription factors or differentiation markers (Figure 1C, F,
I, L, O, R, U, X).
Both rat and human MLE expressed squamous transcrip-
tion factor, Sox2, in the nuclei of basal cell layer of all
cases (Figure 1E, Q), similar to squamous epithelium. p63
was expressed in 100% (85/85) of rat MLE (Figure 1B).
However, only 38.5% (5/13) of human MLE (Figure 1N)
expressed p63 (p < 0.0001 vs. rat MLE).
Of the two squamous differentiation markers (CK14 and
CK4), CK14 was expressed in basal cells of rat MLE in all
cases, similar to squamous epithelium (Figure 1H). How-
ever, in human MLE, CK14 was negative in all 13 cases (p
< 0.0001, vs. rat MLE; Figure 1T). CK4 was expressed in
54.5% (30/55) of rat MLE (Figure 1K), and in 30.8% (4/
13) of human MLE (Figure 1W). Such a difference was not
statistically significant (p > 0.05).
Expression of intestinal transcription factors and 
differentiation markers in rat and human samples (Figure 
2; Table 2)
Neither rat nor human squamous epithelium expressed
any of the intestinal transcription factors (Cdx2, GATA4
and HNF1α) and differentiation markers (villin and
Muc2) (figures not shown). However, both rat IM (Figure
2B, D, F, H) and human IM (Figure 2J, L, N, P) expressed
all intestinal markers studied, except for one case of
human IM in which GATA4 was not expressed.
Rat MLE did not express Cdx2, GATA4, and HNF1α (Fig-
ure 2A, C, E) in any of the cases. Similar to rat MLE,
human MLE did not express GATA4 and Muc2 (Figure 2K,
M). Interestingly although Cdx2 was not expressed in the
nuclei in any cases, it was detected in the cytoplasm of two
cases (Figure 2I).
Villin, an intestinal differentiation marker, was expressed
in 26.8% (15/56) of rat MLE (Figure 2G), and in 15.4%
(2/13) of human MLE (Figure 2O). Such a difference was
not statistically significant (p > 0.05).Page 3 of 9
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Table 1: Transcription factors and differentiation markers used in this study
Antigen Description Expression Pattern Antibody Source Catalogue No. Conc.
p63 Transcription factor essential for 
squamous epithelium
Nuclei of basal and parabasal 
squamous cells
Santa Cruz Biotechnology 
(Santa Cruz, CA)
sc-8431 (mouse mAb) 0.2 µg/ml
Sox2 (SRY-related HMG 
box gene 2)
Transcription factor essential for 
upper gastrointestinal epithelium
Nuclei of epithelial cells in oral cavity, 
esophagus and stomach
Santa Cruz Biotechnology sc-17320 (goat pAb) 4 µg/ml
CK14 (cytokeratin 14) Squamous differentiation marker Cytoplasm of basal squamous cells Novocastra Laboratories 
Ltd. (Newcastle upon Tyne, 
UK)
NCL-LL002 (mouse mAb) 1:40
CK4 (cytokeratin 4) Squamous differentiation marker Cytoplasm of parabasal squamous 
cells
Sigma-Aldrich (St. Louis, 
MO)
C5176 (mouse mAb) 1:500
Cdx2 (caudal-related 
homeobox 2)
Intestinal transcription factor Nuclei (and occasionally cytoplasm) 
of columnar and goblet cells
BioGenex (San Ramon, CA) MU392-UC (mouse mAb) 1:50
GATA4 (GATA-binding 
protein 4)
Intestinal transcription factor Nuclei of columnar and goblet cells Santa Cruz Biotechnology sc-1237 (goat pAb) 0.25 µg/ml
HNF1α (hepatocyte nuclear 
factor 1α)
Intestinal transcription factor Nuclei of columnar and goblet cells Santa Cruz Biotechnology sc-6547 (goat pAb) 0.4 µg/ml
Villin Intestinal differentiation marker Cytoplasm of columnar and goblet 
cells
NeoMarkers (Fremont, CA) MS-1499 (mouse mAb) 5 µg/ml
Muc2 (mucin 2) Intestinal differentiation marker Cytoplasm of goblet cells Santa Cruz Biotechnology sc-15334 (rabbit pAb) 1:500
BMC Gastroenterology 2008, 8:1 http://www.biomedcentral.com/1471-230X/8/1Discussion
Multilayered epithelium, a hybrid epithelium consisting
of squamous cells in the basal portion and columnar cells
in the superficial layers, was first described in esophageal
biopsies in patients with BE [16]. Human MLE expressed
differentiation markers of both squamous and intestinal
columnar epithelium, suggesting that it might represent a
transitional stage in the metaplastic conversion of squa-
mous to columnar epithelium in BE [12,14]. In this study,
we compared the phenotype of rat MLE versus human
MLE in order to gain further insight into the nature of
MLE, and its potential role in the development of BE.
Table 2: Expression of transcription factors and differentiation markers in tissue samples from EGDA rats and humans
Antigen EGDA Rat Samples
No. of positively stained foci/No. of total foci (%)
Human Biopsy Samples
No. of positively stained foci/No. of total foci (%)
Squamous 
epithelium
MLE Intestinal 
metaplasia
Squamous 
epithelium
MLE Intestinal 
metaplasia
p63a 128/128 (100%) 85/85 (100%) 0/142 (0%) 11/11 (100%) 5/13 (38.5%) 0/3 (0%)
Sox2 114/114 (100%) 71/71 (100%) 0/128 (0%) 11/11 (100%) 13/13 (100%) 0/3 (0%)
CK14a 113/113 (100%) 76/76 (100%) 0/139 (0%) 11/11 (100%) 0/13 (0%) 0/3 (0%)
CK4 116/116 (100%) 30/55 (54.5%) 0/129 (0%) 11/11 (100%) 4/13 (30.8%) 0/3 (0%)
Cdx2 0/114 (0%) 0/77 (0%) 127/127 (100%) 0/11 (0%) 2/13 (15.4%) 3/3 (100%)
GATA4 0/114 (0%) 0/70 (0%) 130/130 (100%) 0/11 (0%) 0/13 (0%) 2/3 (66.7%)
HNF1α 0/100 (0%) 0/54 (0%) 111/111 (100%) N/A N/A N/A
Villin 0/115 (0%) 15/56 (26.8%) 133/133 (100%) 0/11 (0%) 2/13 (15.4%) 3/3 (100%)
Muc2 0/114 (0%) 0/75 (0%) 129/129 (100%) 0/11 (0%) 0/13 (0%) 3/3 (100%)
a Statistically significant difference between rat and human MLE (p < 0.0001).
Expression of squamous transcription factors (p63, Sox2) and differentiation markers (CK4, Ck14) in squamous epithelium, MLE and IM of EGDA rats d huma sFigure 1
Expression of squamous transcription factors (p63, Sox2) and differentiation markers (CK4, Ck14) in squamous epithelium, 
MLE and IM of EGDA rats and humans. All the tissue sections were stained immunohistochemically with a specific antibody, 
and then histochemically with Alcian blue. Light blue: Alcian blue staining of acidic mucin; dark blue: hematoxylin staining for 
nuclei; dark brown: immunohistochemical staining. Size bar equals 20 µm in rat samples, or 40 µm in human samples.Page 5 of 9
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BMC Gastroenterology 2008, 8:1 http://www.biomedcentral.com/1471-230X/8/1We focused on squamous transcription factors (p63,
Sox2) and differentiation markers (CK4, CK14), and
intestinal transcription factors (Cdx2, GTAT4, HNF1α)
and differentiation markers (villin, Muc2). Transcription
factors represent "master switch" genes, which regulate
expression of differentiation-related molecules with both
structural and functional specificity, and, thus, mediate
metaplasia. Using immunohistochemical staining we
found that both rat and human MLE simultaneously
expressed markers of both squamous and intestinal differ-
entiation, and that with minor exceptions, rat and human
MLE shared similar expression patterns of these markers.
For instance, we found that rat MLE is more likely to
express p63 and CK14 compared to human MLE.
The squamous transcription factors and differentiation
markers evaluated in this study include p63, Sox2, CK4
and CK14. P63 is a critical initiator of epithelial stratifica-
tion and a key regulator of cell adhesion and survival in
progenitor cells in squamous epithelium [20-22]. In
mouse esophagus, when basal cells become differenti-
ated, p63 is down-regulated and eventually turned off in
terminally differentiated superficial cells [15,23]. In p63-
deficient mice, embryonic esophageal epithelium appears
columnar containing both ciliated and goblet-like cells
[24]. Previous studies have shown that p63 is expressed in
the basal and suprabasal cell layers, and in submucosal
glands, of human esophageal squamous epithelium
[15,25]. p63 in esophageal epithelial cells was downregu-
lated when they were exposed to bile and acid [26]. In this
study, p63 was detected in all cases of rat MLE, but in only
38.5% (5/13) of human MLE (p < 0.0001). This result
suggests that rat and human MLE show differences in their
native esophageal epithelium, and that basal cells of rat
Expression of intestinal transcription factors (Cdx2, GATA4, HNF1α) and differentiation markers (villin, Muc2) in MLE and IM of EGDA rats and humansFigure 2
Expression of intestinal transcription factors (Cdx2, GATA4, HNF1α) and differentiation markers (villin, Muc2) in MLE and IM 
of EGDA rats and humans. All the tissue sections were stained immunohistochemically with a specific antibody, and then histo-
chemically with Alcian blue. Light blue: Alcian blue staining of acidic mucin; dark blue: hematoxylin staining for nuclei; dark 
brown: immunohistochemical staining. Size bar equals 20 µm in rat samples, or 40 µm in human samples.Page 6 of 9
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BMC Gastroenterology 2008, 8:1 http://www.biomedcentral.com/1471-230X/8/1MLE maintain a higher degree of "squamous" differentia-
tion compared to rat MLE. It is known that rat esophagus
is covered by keratinized squamous epithelium and
human esophagus by non-keratinized squamous epithe-
lium.
As a member of the Sry-like high mobility group domain
protein family, Sox2 may play an important role in the
development of the upper gastrointestinal tract. It is
expressed in the pharynx, esophagus, and stomach of
chicken gut, but not in the lower gastrointestinal tract,
where Cdx1 and Cdx2 are present and play an important
role in cell differentiation [27,28]. Sox2 mutations are
associated with esophageal atresia in anophthalmia-
esophageal-genital syndrome [29], and its down-regula-
tion is associated with intestinal metaplasia in the stom-
ach [30,31]. Hypomorphic Sox2 mice developed
metaplastic changes of morphology and gene expression
in the esophagus [32]. Our data showed that Sox2 was
expressed in both rat and human MLE in all cases. In
intestinal metaplasia, Sox2 was negative in both rat and
human samples. Recently, Sox2 was reported to be
silenced by promoter methylation in intestinal-type gas-
tric cancer [33]. Further studies are needed to understand
the mechanisms by which Sox2 is turned off in metaplas-
tic columnar epithelium.
CK4 and CK14 are differentiation markers of esophageal
squamous epithelium. CK14 is typically expressed in
basal cells and CK4 in parabasal cells [34]. Interestingly,
in our study, CK14 was not expressed in human MLE, but
it was expressed in all cases of rat MLE. This expression
pattern was similar to that of p63 in rat and human MLE,
likely due to the fact that CK14 is a transcriptional target
of p63 [35]. Nevertheless, these data support the theory
that rat MLE maintains a higher level of "squamous" dif-
ferentiation compared to human MLE. In the presence of
gastroesophageal reflux, human esophagus was more
likely to lose squamous differentiation features.
We also evaluated intestinal transcription factors (Cdx2,
GATA4 and HNF1α) and differentiation markers (villin
and Muc2). As a member of the Caudal-related homeobox
gene family, Cdx2 is important for skeletal and intestinal
development. Cdx2 plays an important regulatory role in
the development of intestinal metaplasia in the foregut,
and in cancer development in the colon [36,37]. Cdx2 is
normally not expressed in squamous cells of the normal
human esophagus. However, one previous study showed
that a low level of Cdx2 mRNA was detected in biopsy
samples of esophageal squamous epithelium in patients
with esophagitis [11,38]. In BE, Cdx2 is expressed in gob-
let and non-goblet cells [39]. In fact, several Cdx2-regu-
lated genes are known "markers" of BE, such as villin,
guanylate cyclase C, and sucrase isomaltase [40-42]. We
recently demonstrated that treatment of esophageal epi-
thelial cells with acid, bile acids or both resulted in pro-
moter demethylation and activation of Cdx2 [43]. In this
study, Cdx2 was negative in all rat MLE samples, which
suggests that Cdx2 is not expressed at an early stage of
columnar metaplasia. However, in human MLE, two cases
expressed Cdx2 in the cytoplasm, although none of them
showed nuclear expression. Similarly, cytoplasmic expres-
sion of Cdx2 has been reported in the columnar epithe-
lium of colon, bile duct and stomach [44-46]. The
significance of cytoplasmic accumulation of Cdx2 is still
unclear.
GATA4 belongs to a subfamily of the GATA transcription
factor family involved in differentiation of mesoderm and
endoderm-derived tissues. GATA4, 5 and 6 are expressed
in the stomach and small intestine, but not in the esopha-
gus [47-49]. HNF1α is a liver-enriched homeodomain-
containing transcription factor, which regulates many
genes in liver and pancreas [50,51]. Intestinal transcrip-
tional factors (GATA4, HNF1α, and Cdx2) have been
shown to play cooperative roles in regulating the expres-
sion of several marker genes in intestinal epithelium and
human BE [40,50,51]. In this study, neither rat nor
human MLE expressed GATA4 or HNF1α, suggesting that
GATA4 and HNF1α are probably not involved at an early
stage of conversion from squamous to columnar epithe-
lium in the esophagus.
Villin is an actin-bundling protein and a marker of human
BE [19,52-54]. Muc2 is a differentiation marker of intesti-
nal and tracheobronchial goblet cells [55], and is known
to be regulated by Cdx2 in esophageal epithelial cells
[9,43]. In this study, villin was expressed in a small per-
centage of rat and human MLE, whereas Muc2 was not
expressed in either type of tissues. These data suggest that
the mucinous cells in MLE do not possess some biological
properties of fully developed goblet cells. It is possible
that, during the metaplastic conversion of squamous to
columnar epithelium, villin is expressed at an early phase,
whereas Muc2 is expressed only when phenotypically
mature goblet cells develop. Although villin is a possible
transcriptional target of Cdx2 [41], our data suggest that
other factors may regulate its expression in MLE.
The mechanism of intestinal metaplasia is still unclear.
Our data in rat model strongly support the theory that
stem cells reside in the esophagus. Three theories have
been proposed for the development of intestinal metapla-
sia in human BE. The de novo metaplasia theory proposes
that the stem cells of inflamed squamous epithelium are
stimulated by reflux to undergo columnar metaplasia. The
transitional zone metaplasia theory suggests that epithe-
lial cells at the squamocolumnar junction colonize the
gastric cardia or distal esophagus in response to reflux.Page 7 of 9
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BMC Gastroenterology 2008, 8:1 http://www.biomedcentral.com/1471-230X/8/1The esophageal gland duct cell metaplasia theory pro-
poses that stem cells are located in the neck of submucosal
gland ducts, and they are stimulated to expand upon deep
ulceration of the mucosa and submucosa [5]. However,
rats do not have submucosal glands or ducts in their
esophagus, and rat MLE is commonly found in the mid-
esophagus unrelated to the neo-squamocolumnar junc-
tion after EGDA surgery. Thus, development of MLE in
EGDA rats supports pluripotent stem cells in the esopha-
gus as the cellular origin of intestinal metaplasia. This
hypothesis is consistent with previous studies suggesting
gut regenerative cell lineage as the likely cellular origin of
BE [56]. Although MLE is likely a precursor lesion of BE, it
can not be excluded that MLE may be a distinct multi-
directional differentiation type of epithelium, which may
not develop into BE.
Conclusion
In summary, this study shows that rat MLE is similar to
human MLE in the expression pattern of markers of squa-
mous and intestinal differentiation. Further studies are
warranted to determine how these markers are modulated
by gastroesophageal reflux, and how they cooperate with
each other to facilitate columnar metaplasia.
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